Jeff Coller, Ph.D., a Bloomberg Distinguished Professor of RNA Biology at Johns Hopkins, and Michelle Kim, Ph.D., Managing Director of the Johns Hopkins RNA Innovation Center, share insights into the rapid growth of RNA therapeutics. They discuss the Center's role in supporting RNA innovators, the collaborative approach to improve access to cheaper RNA materials, and the transformative potential of mRNA technology in healthcare. The conversation also touches on the evolving partnerships between academia and industry, emphasizing the importance of addressing challenges in RNA technology.